
Infosys Surges on Strong Q1 Earnings; Tech Stocks React Amid Market Consolidation Fears
Markets remained under sustained pressure on Thursday as the broader index extended its losing streak for the fourth consecutive session. This persistent weakness is attributed to ongoing geopolitical concerns permeating global markets. Technically, analysts note that the Nifty has once again retested the lower boundary of its current consolidation range, which sits between 23,800 and 24,400. A decisive breach below this support level could signal a further decline towards the 23,600 zone, aligning with the rising trendline support structure.Infosys Posts Robust Q1 Results, Driving IT Sector Interest
IT services major Infosys reported significantly strong results for its first quarter. The company recorded a consolidated net profit of Rs 7,769 crore, marking a 12% year-on-year (YoY) growth. This is a marked improvement from the previous year's quarterly net profit of Rs 6,921 crore. Furthermore, revenue from operations in the reporting period increased by 14% YoY, reaching Rs 48,211 crore.Meesho Improves Operating Metrics and Narrows Quarterly Loss
Marketplace platform Meesho also reported a positive trend in its operating metrics. The company successfully narrowed its June-quarter loss, largely thanks to a sharp rise in marketplace revenue. Stronger user engagement, improved delivery conversion, and better platform monetization efforts contributed to this improvement. For the quarter ending June 30, 2026, Meesho registered a loss of Rs 133 crore, down from a loss of Rs 289 crore in the corresponding previous quarter.Cipla Faces Profit Decline Despite Record Domestic Revenue
Cipla reported challenges regarding profitability despite strong domestic market performance. The pharmaceutical company recorded a 39% fall in consolidated net profit for the June quarter, coming in at Rs 789 crore. This decline was attributed to weakness observed in its North America business and lower operating margins. However, the firm managed to achieve record revenue from its domestic market operations.Suzlon Secures Major Wind Energy Project Order
Suzlon Energy announced a significant development on Thursday. The company secured a crucial 201.6MW wind energy project order. This contract was awarded by Waaree Forever Energies and is situated in Andhra Pradesh, signaling continued momentum in the renewable sector.IndiGo Reports Q1 Loss After Increased Revenue
Budget carrier IndiGo reported its first quarter results, noting a loss of Rs 238 crore. This contrasts sharply with the profit of Rs 2,176 crore recorded during the same quarter last year. Despite the net loss, revenue from operations did increase by 20% YoY, reaching Rs 24,584 crore for the quarter.Corporate Acquisitions and API Resolution in Big Pharma
Wipro is set to expand its consumer portfolio through a strategic acquisition. Wipro Consumer Care & Lighting will acquire TTK Healthcare Ltd’s Good Home and Eva brands. This move involves an investment of Rs 256 crore, allowing the company to bolster its presence in home care and personal care segments amid increasing industry focus on acquisitions for growth.Additionally, Dr Reddy's Laboratories is working toward resuming essential drug supplies. Chief executive Erez Israeli stated that the company expects to resume supplying its generic semaglutide by November. This resumption follows the resolution of quality issues related to the active pharmaceutical ingredient (API) that previously necessitated a halt in shipments.
Key Companies To Report Q1 Results
The stock markets are also keenly awaiting first quarter results from several prominent companies. These include NTPC, Shriram Finance, SBI Life, Bank of Baroda, Tata Consumer, and Sterlite. Investors across these sectors remain focused on the outcomes of their earnings announcements.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.